Caricamento...
Designing Clinical Trials for Anti-Inflammatory Therapies in Cystic Fibrosis
The inflammatory response in the CF airway begins early in the disease process and becomes persistent through life in most patients. Inflammation, which is predominantly neutrophilic, worsens airway obstruction and plays a critical role in the development of structural lung damage. While cystic fibr...
Salvato in:
| Pubblicato in: | Front Pharmacol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Frontiers Media S.A.
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7516261/ https://ncbi.nlm.nih.gov/pubmed/33013419 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.576293 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|